Lisata Therapeutics annual revenue
2010
2011
2012
2013
2014
2015
2016
2022
2023
2024
2025
Lisata Therapeutics reported $170,000 in revenue for fiscal 2025, a decrease of 83.00% from the previous fiscal year.
View full Lisata Therapeutics company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $170,000 | −$830,000 | −83.00% |
| 2024 | 2024-12-31 | $1.0M | $1.0M | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | −$35.3M | −100.00% |
| 2016 | 2016-12-31 | $35.3M | $12.8M | +56.90% |
| 2015 | 2015-12-31 | $22.5M | $4.5M | +25.36% |
| 2014 | 2014-12-31 | $17.9M | $3.3M | +22.30% |
| 2013 | 2013-12-31 | $14.7M | $338,566 | +2.36% |
| 2012 | 2012-12-31 | $14.3M | $4.3M | +42.58% |
| 2011 | 2011-12-31 | $10.1M | −$59.8M | −85.61% |
| 2010 | 2010-12-31 | $69.8M | — | — |
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Lisata Therapeutics filings at SEC.gov ↗